Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Study Location:

Skip to Main Content

Keep up to date

Sign up for news and information about taking part and shaping research.

English | Cymraeg
Be Part of Research - Trial Details - IRCI Gynae Sarcomas, High Grade Uterine Sarcoma

IRCI Gynae Sarcomas, High Grade Uterine Sarcoma

Not Recruiting

Open to: Female

Age: 18 Years - N/A

Medical Conditions

Uterine Sarcoma

This information is provided directly by researchers and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information.

This study aims to investigate a drug called Cabozantinib which belongs to a family of drugs that have effects on tumour growth, blood supply, invasion and spread. Therefore, we want to find out whether taking cabozantinib after treatment with surgery and chemotherapy is effective and safe for patients who responded or had stable disease after their chemotherapy. All participants will receive 4-6 cycles of standard chemotherapy. Those with stabilization or response to the standard chemotherapy will be split into 2 groups (cabozantinib or placebo).

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

Feb 2015 Mar 2022


Intervention Type : Drug
Intervention Arm Group : Cabozantinib;Placebo

Intervention Type : Drug
Intervention Arm Group : Placebo

You can take part if:

You may not be able to take part if:

This is in the inclusion criteria above

Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • Nottingham University Hospitals NHS Trust - City Hospital
  • Royal Marsden Hospital
  • Cambridge University Hospital NHS - Addenbrookes Hospital
  • Oxford University Hospitals NHS Trust - Churchill Hospital
  • NHS Greater Glasgow and Clyde - Beatson West of Scotland Cancer Centre - Gartnavel General Hospital
  • Leeds Teaching Hospitals NHS Trust - St. James's University Hospital
  • University College London Hospitals NHS Foundation Trust - University College Hospital

The study is sponsored by European Organisation for Research and Treatment of Cancer - EORTC and funded by Gynecologic Oncology Group; NHS Greater Glasgow and Clyde.

We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.

Is this study information helpful?

What will you do next?

Read full details for Trial ID: NCT01979393
Last updated 05 February 2024

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.